Ranitidine HCI 150mg tablet & 50mg/2ml injection

Business Unit: Human

Medicine Type: Injectable Tablet

Generic Name: Ranitidine HCI 150mg tablet & 50mg/2ml injection

Therapeutic Class: Histamine receptor blocker

Indication: Ranix is formulation of Ranitidine which is known as H2 receptor antagonist. Ranix is indicated for Peptic Ulcer Disease (PUD), Gastroesophageal Reflux Disease (GERD), Zollinger-Ellison syndrome, Upper gastrointestinal bleeding and Stress ulcers.

Dosage & Administration: Oral: 150 mg 2 times a day, or 300 mg once a day after the evening meal . or at bed time. Parenteral: 50 mg, IV or IM, every 6 to 8 hours for up to 8 weeks

Preparation: 2ml x 10 Injection